GLI1 and esophageal squamous cell carcinoma: Although both FAK and Gli1 are the critical targets for the development of antitumor agents, the correlation between intratumoral FAK and HH/Gli1 pathways in ESCC, especially in the presence of TME, has not been yet explored.